Best Doctors for Robotic Prostatectomy in Delhi NCR, India

Delhi NCR holds more established robotic surgery programmes than any other Indian region, and for this operation the programme matters as much as the machine.

1. Programme Age, Not Equipment

Every large hospital advertises the same robotic system. What separates them is how long the prostate unit has been running it, and how many of these operations the surgeon at the console does in a month.

Ask both questions directly. A programme running for a decade has worked out its own theatre routine, its own anaesthetic approach and its own pathology reporting. A robot installed last year in a hospital new to the technique is a different proposition.

2. The Easiest Region to Reach

Indira Gandhi International takes direct flights from much of East, West and Southern Africa, the Gulf and Central Asia. For many patients that means one flight rather than two, with no overnight in a third country.

That matters more than it sounds for this operation, because you will make the journey twice and the second time you will be recovering.

3. The Plan Should Come From a Board

Prostate cancer is one of the areas where the decision to operate at all deserves scrutiny. Some cancers found on biopsy are better monitored than removed, and radiotherapy is a real alternative for many men rather than a fallback.

Your case should go to a multidisciplinary meeting where the urologist, medical oncologist, radiation oncologist, radiologist and pathologist agree the plan together. Ask whether it will, and ask for the conclusion in writing. The large NCR centres run these as routine.

4. Consultations in English

Clinical work at the major hospitals runs in English, so you can read your own pathology and imaging reports and carry home a discharge summary your own doctors can act on. Interpreters for Arabic, French, Russian and Kiswahili are available at most of the hospitals in this directory, arranged before you arrive.

5. Timing and Air Quality

Air quality across the region is poor from roughly late October to January. For this operation that changes little, but raise it with your surgeon if either applies:

• You have asthma or another chronic lung condition

• You are concerned about a long procedure under general anaesthesia

February to April and September to October are the most comfortable months. May and June are hot, which affects recovery outside hospital more than the surgery itself. None of this justifies delaying treatment for a diagnosed cancer.

1. What Robotic Radical Prostatectomy Involves

Robotic radical prostatectomy is the surgical removal of the entire prostate gland, together with the seminal vesicles, for the treatment of prostate cancer. The bladder is then reconnected directly to the urethra. It is performed through several small abdominal incisions rather than one long one.

"Robotic-assisted" describes how the surgeon reaches the prostate, not a different operation. The surgeon sits at a console in the same theatre and controls every instrument and every movement. The system holds the instruments and the camera, translates hand movements into finer ones, and filters natural tremor. It makes no decisions and moves nothing independently.

Robotic access is one approach to radical prostatectomy. Whether radical prostatectomy is the right treatment for you is a separate question, decided by the characteristics of your cancer, your general health, your life expectancy and your own preferences.

2. Who May Be a Candidate

Radical prostatectomy is generally considered for cancer that appears confined to the prostate, in patients well enough for a substantial operation and with sufficient life expectancy to benefit from treating the cancer.

Suitability is assessed against several findings together rather than any single one:

• PSA level, and how it has changed over time

• Biopsy findings, including how many cores contain cancer

• Grade Group, derived from the Gleason score

• Prostate MRI, and what it shows about the gland capsule and surrounding tissue

• Clinical stage

• Where the tumour sits within the gland, and how far it extends

• The resulting risk category

• Life expectancy and general fitness for anaesthesia

• Your own priorities, including how you weigh continence and sexual function against other considerations

Not every patient with prostate cancer is a candidate for surgery, and not every candidate should have it. Some cancers are better monitored. Some are better treated with radiotherapy. Some require systemic treatment as the central approach.

3. Is Surgery Right for Every Prostate Cancer?

No. Prostate cancer covers a wide range of disease, from tumours that may never cause harm to cancer that has already spread. Treatment is matched to risk category, and surgery is one option among several.

Low-risk disease

For appropriately selected patients with low-risk prostate cancer, active surveillance is a recognised management strategy supported by EAU and AUA guidance. It means monitoring the cancer with PSA testing, examination, imaging and repeat biopsy, and treating only if the disease shows signs of progressing.

Surveillance is not the same as ignoring the cancer, and it is not a lesser option. For some men it avoids or delays the side effects of treatment without compromising cancer control. Ask whether you are a candidate for it before agreeing to surgery.

Intermediate-risk disease

Intermediate-risk prostate cancer covers a broad span, and guidance generally distinguishes favourable from unfavourable subgroups. Management may involve radical prostatectomy or radiotherapy, and for some favourable cases surveillance may still be discussed.

The choice depends on which subgroup you fall into, your life expectancy, your other medical conditions and your own preferences about the different side effect profiles. Both surgery and radiotherapy are established treatments here. Neither is automatically superior.

High-risk and locally advanced disease

Selected patients with high-risk or locally advanced prostate cancer may undergo radical prostatectomy, usually as one component of a broader strategy rather than as a single definitive treatment.

Management commonly involves more than one specialty, and additional treatment such as radiotherapy or systemic therapy may be planned from the outset or added depending on findings. If you are in this group, the multidisciplinary discussion matters more, not less.

Metastatic disease

Where prostate cancer has spread beyond the pelvis, radical prostatectomy is not generally the default treatment. Systemic therapy is usually central to management.

Surgery may occasionally have a role in specific circumstances, but it is not the standard approach and should not be presented as one. If you have been told you have metastatic disease and offered prostatectomy as the primary treatment, seek a second opinion before proceeding.

4. How the Decision Is Reached

Assessment usually moves through a recognised sequence, though not every patient follows it in the same order and some steps may be repeated or omitted depending on the clinical situation.

PSA testing. A blood measurement that may prompt further investigation. A raised PSA has several possible explanations and most are not cancer.

Prostate MRI. Imaging that may show suspicious areas, help target biopsy and give information about whether disease extends beyond the gland. Where available, MRI before biopsy is now common practice.

Biopsy. Tissue sampling that establishes whether cancer is present, and if so its grade. Diagnosis rests on biopsy, not on PSA alone.

Grade Group and Gleason score. The pathologist grades how abnormal the cancer cells appear. This is one of the strongest determinants of how the disease is likely to behave.

Clinical staging. An assessment of how far the cancer extends, drawing on examination, imaging and biopsy findings.

Risk classification. The above are combined into a risk category, which shapes which treatments are appropriate to discuss.

Life expectancy and general health. Relevant because some prostate cancers grow slowly enough that treatment may offer little benefit to a patient with limited life expectancy from other causes.

Further imaging when indicated. In selected higher-risk cases, additional imaging such as PSMA PET/CT may be performed to look for spread.

Treatment discussion. Options are presented with their respective benefits and side effects, ideally after multidisciplinary review.

Surgery, when appropriate. Radical prostatectomy proceeds only where it is the agreed approach for that patient.

5. Records to Bring to a Consultation

A urologist reviewing your case remotely or in clinic can give a far more useful opinion with complete records. Bring or send:

• All PSA results, with dates, so the trend is visible rather than a single value

• The prostate MRI report and, where possible, the actual image files rather than only the written report

• The biopsy report in full, including the number of cores taken and the number involved

• Gleason score and Grade Group

• Any other pathology reports

• PSMA PET/CT or other staging imaging, where performed

• Records of any previous prostate treatment, including procedures for an enlarged prostate

• A current list of your medicines

• Relevant medical history, particularly heart, lung and bleeding conditions

• Previous operative reports for any abdominal or pelvic surgery

These documents determine whether nerve preservation can be considered, whether lymph node dissection is likely to be recommended, and whether surgery is the appropriate treatment at all. An opinion given without them is provisional.

6. Robotic, Laparoscopic and Open Surgery Compared

All three are approaches to the same operation. The prostate removed is the same, and the cancer outcome depends principally on patient selection and the quality of the surgery rather than on which approach is used.

Open radical prostatectomy. Access is through a single lower abdominal incision, giving the surgeon direct tactile feedback. It is generally associated with greater blood loss and a longer hospital stay than the minimally invasive approaches. It remains a good operation in experienced hands.

Laparoscopic radical prostatectomy. Access through several small incisions using long rigid instruments and a two-dimensional or three-dimensional camera. Technically demanding. Less widely offered for prostate surgery now that robotic systems are available.

Robotic-assisted radical prostatectomy. Access through several small incisions, with instruments mounted on robotic arms and controlled from a console. Provides magnified three-dimensional vision, instruments that articulate beyond the range of a human wrist, and tremor filtering. Generally associated with less blood loss, shorter hospital stay and faster return to activity.

What the evidence does not show is a clear advantage for the robotic approach in cancer control. Randomised comparison of robotic against open prostatectomy has not demonstrated superior oncological outcomes, and long-term urinary and sexual function have been broadly similar between approaches.

The practical conclusion is simple to state and worth taking seriously. An experienced surgeon using an approach they perform frequently is a better choice than a less experienced surgeon using a newer one. The presence of a robotic system in a hospital tells you about its equipment budget, not about its results.

7. Nerve-Sparing Surgery

Nerve-sparing radical prostatectomy means preserving the neurovascular bundles that run alongside the prostate and carry the nerves involved in erectile function. Where cancer allows, the surgeon separates these bundles from the gland rather than removing them with it.

Whether preservation is possible depends on where the tumour sits, its grade and extent, and what imaging showed about the capsule of the gland. It may be possible on both sides, one side, or neither.

Cancer control takes precedence. A surgeon who preserves nerve tissue at the cost of leaving cancer behind has not served the patient, and the decision may change during the operation based on what is found.

Nerve preservation does not guarantee that erectile function will return to what it was. It improves the chance of recovery rather than assuring it, and outcomes also depend on age, function before surgery and other health factors. Ask whether nerve sparing is planned for you, on which side, and what would prompt your surgeon to abandon it mid-operation.

8. Pelvic Lymph-Node Dissection

Pelvic lymph-node dissection means removing lymph nodes from the pelvis during the same operation so that a pathologist can examine them for cancer. It is a staging procedure: it establishes whether disease has reached the nodes rather than estimating it from imaging.

It is not performed for every patient. Decisions are generally guided by risk category and by the estimated probability of node involvement, so many low-risk patients will not need it while it is commonly recommended in higher-risk cases.

Removing nodes adds to the operation and carries its own risks, including a collection of lymph fluid in the pelvis, which sometimes requires drainage. Ask whether dissection is planned for you, how extensive it would be, and what the finding would change about your subsequent treatment.

9. Risks and Side Effects

Radical prostatectomy is major surgery and carries recognised risks. The two that most affect daily life afterwards are urinary and sexual, and both should be discussed before you consent rather than after.

No percentages are given below. Published figures vary widely by patient population, surgeon, how outcomes were defined and how long patients were followed, and a number quoted without those details is not information. Ask your own surgeon for their own figures and for the definitions behind them.

Urinary incontinence

Leakage of urine is common in the early period after the catheter is removed. For most patients it improves substantially over the following months, and many recover full control.

A minority have leakage that persists and may need further treatment. Recovery is influenced by age, urinary control before surgery, the operation itself and how consistently pelvic floor exercises are performed. Starting those exercises before surgery is generally advised.

Erectile dysfunction

Erectile function usually declines sharply after surgery and then recovers gradually, often over one to two years and sometimes longer. Recovery may be partial, and for some patients function does not return to what it was.

Outcome depends on function before surgery, age, whether nerve preservation was possible, and other health conditions affecting blood vessels and nerves. Rehabilitation approaches exist and are generally started early rather than delayed. Ask what support the unit provides.

Infertility

Radical prostatectomy causes permanent infertility. The prostate and seminal vesicles produce most of the fluid in semen and both are removed, so ejaculation no longer occurs. Orgasm remains possible for many patients, but without ejaculate.

Natural conception is not possible after this operation. If there is any possibility you would want biological children, sperm storage must be arranged before surgery, because it cannot be done afterwards. Raise this at your first consultation rather than waiting for it to be raised with you.

Bleeding

Any operation of this size can involve bleeding, and transfusion is occasionally required. Blood loss is generally lower with minimally invasive approaches than with open surgery.

Infection

Infection can affect the urinary tract, the wound sites or, less commonly, the chest. A catheter in place for a period after surgery is itself a route for urinary infection.

Blood clots

Clots can form in the leg veins and, rarely, travel to the lungs. Preventive measures such as early mobilisation and compression are routine, and additional measures may be used depending on your risk.

Anaesthetic risk

The operation requires general anaesthesia and positioning that can be demanding for some patients. Existing heart and lung conditions are relevant and should be declared fully during assessment.

Injury to nearby structures

The prostate sits close to the bladder, the rectum, the ureters and major blood vessels. Injury to these is uncommon but recognised, and can be serious when it occurs.

A leak may also develop at the join between bladder and urethra in the early period, and a narrowing can form there later.

Lymphocele

Where pelvic lymph nodes have been removed, lymph fluid can collect in the pelvis. Many collections cause no symptoms and resolve without intervention. Some cause pain, swelling or pressure and require drainage.

10. Recovery, Stage by Stage

Recovery varies between patients and depends on the surgeon's protocol, the extent of the operation and your own progress. The stages below describe the usual pattern rather than a timetable you should expect to match.

Immediately after surgery

You wake in a recovery area with a urinary catheter in place and pain relief provided. Nursing staff monitor you closely for the first hours.

Hospital recovery

Most patients spend a small number of nights in hospital. Walking is usually encouraged from the day after surgery, and breathing exercises may be advised. You will normally go home with the catheter still in place.

The catheter period

The catheter remains for a period while the join between bladder and urethra heals, commonly one to two weeks, and it is removed at a follow-up visit. Some units perform an imaging check of the join before removing it.

You should not undertake long-distance travel with the catheter in place, or immediately after its removal, until you have passed urine successfully and been reviewed.

The first few weeks

Fatigue is normal and often underestimated. Heavy lifting and strenuous exercise are usually restricted for several weeks, driving is typically avoided for a period, and sexual activity is usually deferred for around four to six weeks.

Ask your surgeon for their specific restrictions in writing, since protocols differ between units.

Return to normal activities

Most patients resume ordinary daily activity within several weeks, with a return to more demanding work or exercise taking longer. Recovery is not linear and setbacks are common rather than alarming.

Urinary recovery

Continence usually improves progressively over months rather than days. Pelvic floor exercises are the mainstay, performed consistently. Persistent leakage beyond the expected period should be reviewed rather than accepted.

Sexual function recovery

Recovery of erectile function is the slowest element and may continue over one to two years. It is generally managed actively rather than waited out. Discuss what is available before you leave.

Long-term follow-up

PSA monitoring continues for years, with intervals set by your team. Follow-up is not a formality: it is how recurrence is detected early enough to treat.

11. The Pathology Report

The removed prostate is examined by a pathologist, and the resulting report gives more accurate information than any pre-operative test could. It commonly assesses:

• The type of cancer

• Grade Group and Gleason characteristics, which may differ from the biopsy result

• Pathological stage, including whether cancer extended beyond the gland

• Surgical margins, meaning whether cancer reached the cut edge of the removed tissue

• Lymph node involvement, where nodes were removed

• Other features such as involvement of the seminal vesicles

This report determines what happens next. It may confirm the pre-operative assessment, or it may show more extensive disease than expected and prompt discussion of further treatment.

Ask for a copy before you leave the country, and ask your surgeon to explain what each element means for you. Ask also, before surgery, what the plan would be if the pathology comes back less favourable than the imaging suggested.

12. PSA Monitoring After Surgery

Once the prostate has been removed, PSA should fall to a very low level, because the gland that produces most of it is gone. PSA then becomes the principal tool for monitoring.

Testing usually begins some weeks after surgery, then continues at intervals set by your team, often for years. Clinical review accompanies it, the pathology report informs how closely you are watched, and imaging is used when there is a specific reason rather than routinely.

What a rising PSA may mean

A rising PSA after prostatectomy may indicate that prostate cancer cells remain somewhere in the body. It does not by itself mean the cancer has returned in a form that requires immediate treatment, and a single detectable reading is not a diagnosis.

Interpretation depends on the context: how high the value is, how quickly it is changing, which laboratory assay was used, how long after surgery it was measured, and what the pathology showed. A very low but detectable value may be watched with repeat testing rather than acted on.

The term used clinically is biochemical recurrence, and definitions of it vary between guidelines and assays. If your PSA becomes detectable, the appropriate response is discussion and repeat measurement, not alarm. Ask which threshold your team uses and what they would do at each stage.

13. When Further Treatment May Be Needed

Some patients require additional treatment or investigation after prostatectomy. Whether that applies depends on the pathology findings, how PSA behaves over time, the risk category, imaging results and whether recurrence is identified.

Additional treatment may involve radiotherapy to the area where the prostate was, systemic treatment, or a combination, and the timing of it is itself a clinical decision. Some patients are treated soon after surgery on the basis of pathology; others are monitored and treated only if PSA rises.

This page cannot tell you which applies to you, and no page should try. What it can tell you is to ask the question in advance, so that a less favourable pathology report is a discussion you were prepared for rather than a shock.

14. Choosing a Surgeon

Years in practice is a weak measure on its own, and a long career does not by itself indicate better surgical results. Consider these instead:

• Qualification in urology, and specific training or fellowship in uro-oncology

• How much of the surgeon's practice is prostate cancer rather than general urology

• Their volume of robotic radical prostatectomy specifically, not robotic surgery in general

• Experience with nerve-preserving technique where that is relevant to your case

• Whether the hospital has an established robotic programme rather than recent equipment

• Access to a multidisciplinary meeting, and evidence that cases go through it

• The pathology service, and whether specimens are reported by pathologists who see prostate work regularly

• Arrangements for follow-up, including whether remote review is possible if you live abroad

• Whether the surgeon reviews your imaging and pathology personally

• How clearly they explain uncertainty, and whether they raise risks without being asked

• Transparency about expected costs, including what an estimate excludes

15. Questions to Ask Before You Consent

Written answers are more useful than verbal ones, particularly if you are travelling.

• How many robotic radical prostatectomies do you perform in a year, and in a typical month?

• How long have you been performing this operation, and how long has this hospital's programme run?

• What proportion of your practice is prostate cancer and uro-oncology?

• Am I a candidate for nerve-sparing surgery, on one side or both?

• Do I need pelvic lymph-node dissection, and what would the result change?

• What are my alternatives to surgery, including surveillance and radiotherapy, and why do you recommend surgery for me?

• What effect might this have on my urinary continence, and what support is available?

• What effect might this have on erectile function, and when would rehabilitation start?

• Could this affect my fertility, and should I store sperm beforehand?

• Who will report my pathology, and when will I receive it?

• How will my PSA be monitored, and at what intervals?

• What happens if my PSA rises, and at what level would you act?

• Might I need further treatment, and what would that involve?

• What happens, and who pays, if a complication develops while I am still in India?

16. Practical Planning in Delhi NCR

The region covers Delhi plus Gurugram, Noida, Faridabad and Ghaziabad, and the robotic programmes are spread across all of them. A hospital described as being in Delhi may sit forty kilometres from another you are comparing it against.

Book accommodation within a short drive of your actual hospital. You will return for catheter removal and at least one review, so proximity matters more than being centrally located.

Published quotes for robotic prostatectomy at Delhi-region hospitals sit at roughly 8,000 to 9,000 US dollars, indicative figures checked in August 2026 rather than quotes. Ask for an itemised written estimate and confirm specifically whether it includes complications, extra nights, intensive care, accommodation after discharge and the review appointments.

Total time in the country is usually longer than patients expect. Published guidance ranges from about twelve days to three weeks, and the deciding factor is when the catheter comes out and how the first review goes. Get a timeline in writing before booking a return flight.

For patients travelling from Africa, country guides covering flights, visa documents and costs are available for Tanzania, Kenya, Zambia, Zimbabwe, Ghana and South Sudan.

To compare more widely, see robotic prostatectomy surgeons across India or the best urologists in India. For the operation for an enlarged prostate, which is a different procedure, see TURP for an enlarged prostate. Diagnosis rests on the biopsy that confirms it, and what the operation involves step by step covers the procedure itself.

If your urine stream weakens months after surgery, a narrowing can form where the bladder was rejoined, and surgery to widen the join can correct it.

PSA testing ↓ Prostate MRI (where available, often before biopsy) ↓ Biopsy — establishes diagnosis ↓ Grade Group / Gleason score ↓ Clinical staging ↓ Risk classification ↓ Life expectancy and general health assessed ↓ Further staging imaging in selected higher-risk cases ↓ Multidisciplinary discussion of options ↓ Active surveillance | Radiotherapy | Radical prostatectomy | Systemic therapy